Cartagenia delivers diagnostic knowledge, software and database systems, and related services that enable genetic labs and clinicians to perform clinically relevant genetic analyses quickly and efficiently, and allow them to offer patients and carers high quality genetic interpretation and counseling. Genetics is one of medicine’s fastest growing fields as man’s ability to capture, store and interpret genetic data expands exponentially. In 2015, Cartagenia was acquired by Agilent Technologies.
Location: United States, Massachusetts, Cambridge
Total raised: $8.85M
Investors 1
| Date | Name | Website |
| - | KU Leuven ... | lrd.kuleuv... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 29.05.2014 | - | $5.9M | - |
| 06.10.2011 | - | $2.95M | - |
Mentions in press and media 3
| Date | Title | Description | Source |
| 30.05.2014 | Cartagenia Closes $5.9M | LEUVEN, BELGIUM, Leading provider of clinical-grade solutions for genomic assay interpretation and... | vcnewsdail... |
| 29.05.2014 | Cartagenia Closes $5.9M Financing Round | Cartagenia, a Leuven, Belgium-, and Cambridge, MA-based provider of clinical-grade solutions for gen... | finsmes.co... |
| 06.10.2011 | Cartagenia Raises €2.2M in Funding | Cartagenia, a Leuven, Belgium-based provider of knowledge, software and services for efficient patie... | finsmes.co... |